Trials / Completed
CompletedNCT01421654
Evaluation of Acclimate Feature for Positive Airway Pressure (PAP) Therapy
Evaluation of Positive Airway Pressure (PAP) Feature to Improve Patient Adherence to Therapy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- ResMed · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to evaluate if using the Acclimate feature at the beginning of Positive Airway Pressure (PAP) therapy results in patients using their PAP therapy at least as long as they would standard therapy. Additionally, the Acclimate feature will be evaluated with regard to patient comfort, ease of acceptance of PAP therapy, leak events, and respiratory events.
Detailed description
Acclimate has been designed as a comfort feature for patients starting PAP therapy. The feature allows acclimatization to the targeted positive airway pressure setting. Using the Acclimate feature, the pressure increases incrementally over a period of time. The feature can be only be used for a set period of time, afterwards which the device initiates the therapeutic session at the prescribed pressure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | S9 Elite with Acclimate | S9 Elite Flow Generator with Acclimate feature activated |
| DEVICE | S9 Elite | S9 Elite Flow Generator |
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2011-12-01
- Completion
- 2011-12-01
- First posted
- 2011-08-23
- Last updated
- 2013-03-12
- Results posted
- 2013-03-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01421654. Inclusion in this directory is not an endorsement.